X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (23) 23
male (16) 16
female (13) 13
gastroenterology & hepatology (13) 13
middle aged (13) 13
aged (12) 12
index medicus (12) 12
oncology (9) 9
adult (8) 8
chemotherapy (8) 8
antineoplastic combined chemotherapy protocols - therapeutic use (7) 7
cancer (7) 7
survival (7) 7
treatment outcome (7) 7
aged, 80 and over (6) 6
deoxycytidine - analogs & derivatives (5) 5
gemcitabine (5) 5
life sciences (5) 5
metastasis (5) 5
prognosis (5) 5
analysis (4) 4
clinical trials (4) 4
combination (4) 4
fluorouracil - administration & dosage (4) 4
fluorouracil - therapeutic use (4) 4
metastases (4) 4
patients (4) 4
5-fluorouracil (3) 3
[sdv.can]life sciences [q-bio]/cancer (3) 3
cisplatin (3) 3
colorectal cancer (3) 3
deoxycytidine - administration & dosage (3) 3
deoxycytidine - adverse effects (3) 3
disease-free survival (3) 3
folfirinox (3) 3
medical prognosis (3) 3
metastatic (3) 3
oxaliplatin (3) 3
pancreatic cancer (3) 3
pancreatic neoplasms - drug therapy (3) 3
quality of life (3) 3
rectal neoplasms - pathology (3) 3
remission induction (3) 3
studies (3) 3
surgery (3) 3
therapy (3) 3
trial (3) 3
abridged index medicus (2) 2
adenocarcinoma (2) 2
adenocarcinoma - drug therapy (2) 2
antigenic determinants (2) 2
antimetabolites, antineoplastic - administration & dosage (2) 2
antimetabolites, antineoplastic - adverse effects (2) 2
antimetabolites, antineoplastic - therapeutic use (2) 2
antineoplastic combined chemotherapy protocols - administration & dosage (2) 2
apoptosis (2) 2
camptothecin - administration & dosage (2) 2
camptothecin - analogs & derivatives (2) 2
cancer therapies (2) 2
carcinoma (2) 2
care and treatment (2) 2
cell survival (2) 2
cholangiocarcinoma (2) 2
cisplatin - administration & dosage (2) 2
classification (2) 2
colon (2) 2
colorectal neoplasms - drug therapy (2) 2
colorectal neoplasms - pathology (2) 2
deoxycytidine - therapeutic use (2) 2
docetaxel (2) 2
drug therapy (2) 2
endocrine carcinoma (2) 2
epitopes (2) 2
failure (2) 2
fluoropyrimidine (2) 2
fluorouracil (2) 2
folfox (2) 2
france (2) 2
gastroenterology and hepatology (2) 2
gastrointestinal hemorrhage - etiology (2) 2
health aspects (2) 2
hematology (2) 2
human papillomavirus (2) 2
infections (2) 2
intermediate-cell carcinoma (2) 2
internal medicine (2) 2
leucovorin (2) 2
leucovorin - administration & dosage (2) 2
leucovorin - therapeutic use (2) 2
liver neoplasms - pathology (2) 2
liver neoplasms - secondary (2) 2
medical research (2) 2
mitomycin (2) 2
neoplasm metastasis (2) 2
neoplasm staging (2) 2
neuroendocrine tumors (2) 2
oral capecitabine (2) 2
organoplatinum compounds - administration & dosage (2) 2
paclitaxel (2) 2
pancreatic adenocarcinoma (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Annals of Surgery, ISSN 0003-4932, 11/2019, Volume 270, Issue 5, pp. 747 - 754
OBJECTIVE:The aim of this study was to report the 3-year survival results of the GRECCAR-6 trial. SUMMARY BACKGROUND DATA:Current data on the effect of an... 
Journal Article
Journal Article
Cancer, ISSN 0008-543X, 09/2015, Volume 121, Issue 18, pp. 3290 - 3297
Journal Article
Journal Article
Journal Article
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, ISSN 1756-283X, 09/2019, Volume 12, p. 175628481987866
Background: Folfirinox (FFX) and gemcitabine/nab-paclitaxel (GN) are both standard first-line treatments in patients with metastatic pancreatic cancer (mPC).... 
PLUS GEMCITABINE | pancreatic adenocarcinoma | metastatic | survival | nab-paclitaxel | Folfirinox | gemcitabine | GASTROENTEROLOGY & HEPATOLOGY
Journal Article
European Journal of Cancer, ISSN 0959-8049, 04/2019, Volume 111, pp. 94 - 106
Journal Article
BMC Cancer, ISSN 1471-2407, 08/2017, Volume 17, Issue 1, pp. 574 - 8
Journal Article
PLoS ONE, ISSN 1932-6203, 08/2015, Volume 10, Issue 8, pp. e0135907 - e0135907
Journal Article
Journal Article